WallStreetZenWallStreetZen

NASDAQ: HOLX
Hologic Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Hologic earnings were $557.1M for the trailing 12 months ending Jun 28, 2025, with -17.6% growth year over year. The latest HOLX earnings report on Jun 28, 2025 announced Q2 2025 earnings of $194.9M, down 1,220.1% from last quarter. For the last reported fiscal year 2024 ending Sep 28, 2024, HOLX reported annual earnings of $789.5M, with 73.1% growth. The next HOLX earnings date is Nov 3, 2025.

HOLX past earnings growth

How has HOLX's earnings growth performed historically?

Company
-17.63%
Industry
15.4%
Market
34.36%
HOLX's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
HOLX's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
HOLX's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

HOLX earnings history

Current Revenue
$4.0B
Current Earnings
$557.1M
Current Profit Margin
13.8%
HOLX's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

HOLX Return on Equity

Current Company
11.5%
Current Industry
9.8%
Current Market
30.7%
HOLX's Return on Equity (11.5%)... subscribe to Premium to read more.
High Return on Equity Performance

HOLX undefined

Current Company
6.3%
Current Industry
8.1%
HOLX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when HOLX announces earnings.

HOLX undefined

Current Company
10.15%
Current Industry
10.5%
HOLX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

HOLX vs Medical Stocks

TickerEBITDAEarningsY/Y EarningsEPS
HOLX$1.09B$557.10M+5.27%$2.43
COO$1.13B$407.80M+7.67%$2.04
BAX$941.00M-$155.00MN/A-$0.30
WST$773.90M$487.70M+11.61%$6.72
ATR$809.13M$391.50M+13.34%$5.91
View Top Medical Stocks

HOLX earnings dates

Next earnings date
Nov 3, 2025

Hologic Earnings Reports & History FAQ

What were Hologic's earnings last quarter?

On HOLX's earnings call on Invalid Date, Hologic (NASDAQ: HOLX) reported Q2 2025 earnings per share (EPS) of $0.87, up 4.82% year over year. Total HOLX earnings for the quarter were $194.90 million. In the same quarter last year, Hologic's earnings per share (EPS) was $0.83.

If you're new to stock investing, here's how to buy Hologic stock.

When does Hologic report earnings?

The next HOLX earnings date is Invalid Date. Add HOLX to your watchlist to be reminded of Hologic's next earnings date.

Is Hologic profitable or losing money?

As of the last Hologic earnings report, Hologic is currently profitable. Hologic's net profit (also called net income) for the twelve months ending Jun 28, 2025 was $557.10 million, a 20.58% decrease year over year.

What was HOLX's earnings growth in the past year?

As of Hologic's earnings date in Invalid Date, Hologic's earnings has grown -17.63% year over year. This is 33.03 percentage points lower than the US Medical Instruments & Supplies industry earnings growth rate of 15.4%. HOLX earnings in the past year totalled $557.10 million.

What are Hologic's earnings expectations?

The current EPS estimate for Hologic's earnings report in Invalid Date is $1.10.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.